ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies.

Chantal T Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.